ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08535
0,00%
Bitcoin
68.841,97
-0,61%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Tempest Therpeutics Inc (TPST)

  7. Tempest Therpeutics Inc (TPST) News

TPST

Tempest Therpeutics (TPST)

Tempest Therpeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TPST
DatumZeitQuelleÜberschriftSymbolFirma
21/05/202414h00GlobeNewswire Inc.Tempest to Participate in Upcoming Investor ConferencesNASDAQ:TPSTTempest Therpeutics Inc
13/05/202422h54Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
09/05/202422h29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TPSTTempest Therpeutics Inc
09/05/202422h29GlobeNewswire Inc.Tempest Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TPSTTempest Therpeutics Inc
09/05/202422h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
26/04/202422h05GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
09/04/202414h00GlobeNewswire Inc.Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual MeetingNASDAQ:TPSTTempest Therpeutics Inc
04/04/202414h00GlobeNewswire Inc.Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research CommunicationsNASDAQ:TPSTTempest Therpeutics Inc
19/03/202421h25GlobeNewswire Inc.Tempest Reports Year End 2023 Financial Results and Provides Business UpdateNASDAQ:TPSTTempest Therpeutics Inc
12/03/202413h00GlobeNewswire Inc.Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer TypesNASDAQ:TPSTTempest Therpeutics Inc
05/03/202422h30GlobeNewswire Inc.Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual MeetingNASDAQ:TPSTTempest Therpeutics Inc
26/02/202414h00GlobeNewswire Inc.Tempest to Present at the 44th Annual TD Cowen Healthcare ConferenceNASDAQ:TPSTTempest Therpeutics Inc
15/02/202400h49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
14/02/202420h12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
08/02/202423h41Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
02/02/202422h30GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
05/01/202422h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
05/01/202422h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
05/01/202422h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
05/01/202422h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
05/01/202422h05GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
01/12/202322h15GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
20/11/202314h00GlobeNewswire Inc.Tempest to Present at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:TPSTTempest Therpeutics Inc
17/11/202322h46Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
17/11/202322h45Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
17/11/202322h44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
17/11/202322h44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
17/11/202322h43Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TPSTTempest Therpeutics Inc
17/11/202322h39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TPSTTempest Therpeutics Inc
09/11/202323h28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TPST

Kürzlich von Ihnen besucht

BIT
1BRK
Berkshire Hathaway
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten